Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000049673 | SCV000487278 | likely pathogenic | Neuronal ceroid lipofuscinosis 3 | 2016-11-07 | criteria provided, single submitter | clinical testing | |
Invitae | RCV003531947 | SCV004297710 | pathogenic | Neuronal ceroid lipofuscinosis | 2023-08-14 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 56261). This premature translational stop signal has been observed in individual(s) with CLN3-related conditions (PMID: 21990111). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Thr80Asnfs*12) in the CLN3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CLN3 are known to be pathogenic (PMID: 9311735, 28542676). |
Juha Muilu Group; Institute for Molecular Medicine Finland |
RCV000049673 | SCV000082080 | probable-pathogenic | Neuronal ceroid lipofuscinosis 3 | no assertion criteria provided | not provided | Converted during submission to Likely pathogenic. |